Latest Articles

Publication Date
New fresh look on vimentin's role in endometrial cancer - Universitetet i Bergen

New fresh look on vimentin's role in endometrial cancer Universitetet i Bergen

Published: Oct. 22, 2024, 2:31 p.m.
New fresh look on vimentin's role in endometrial cancer - uib.no

New fresh look on vimentin's role in endometrial cancer uib.no

Published: Oct. 22, 2024, 2:31 p.m.
Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies - Nature.com

Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies Nature.com

Published: Oct. 22, 2024, 2:08 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - Physician's Weekly

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer Physician's Weekly

Published: Oct. 22, 2024, 6:31 a.m.
Research progress on correlative prediction factors and prediction models of endometriosis associated ovarian carcinoma.

Endometriosis is a common benign disease in women of childbearing age, with a malignant change rate of about 1%. Endometriosis associated ovarian cancer (EAOC), which usually occurs in the ovaries, …

Published: Oct. 22, 2024, midnight
Rectal mass: cancer or endometriosis?

Published: Oct. 22, 2024, midnight
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study - Frontiers

A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study Frontiers

Published: Oct. 21, 2024, 6:48 p.m.
How itching 'down there' could be sign of rare cancer & other signs to watch for - The Sun

How itching 'down there' could be sign of rare cancer & other signs to watch for The Sun

Published: Oct. 21, 2024, 6:30 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive

Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive

Published: Oct. 21, 2024, 5:04 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!